2024年会议议程
2024年3月26-27日
2024年会议议程
三十年来，Precision Med TRI-CON 一直是诊断和精准医学界至关重要的国际会议场所。历年来均与数千名国际思想领袖一起讨论实施精准医学、生物标记和伴随诊断、基因组医学和精准健康的最新研究、技术、创新和商业模式；传染病的家庭诊断、护理点检测和分子诊断的创新和市场准入策略；液体活检和精准肿瘤学的先进诊断，包括多癌早期检测和微小残留疾病检测。而2024年的会议更将涵盖更快、更便宜的测序、人工智慧和数位工具以及空间生物学和单细胞多组学对推进精准医学的新兴影响。一起来到阳光明媚的圣地牙哥加入我们吧！TRI-CON将会安排各种现场交流和富有远见且发人深省的主题演讲等您所期待的各种会议活动。
2024年主讲人
FIRESIDE CHAT: Artificial Intelligence Innovation for Precision Medicine
炉边谈话：精准医疗上的人工智慧创新
Eric Topol, MD, Director, Scripps Research Translational Institute; Executive Vice President and Professor, Scripps Research
Interviewed by: Mara G. Aspinall, Partner, Illumina Ventures; Professor of Practice, Arizona State University
Kari Stefansson
CEO
deCODE genetics
Mara Aspinall
Partner
Illumina Ventures
Anthony Sireci
SVP, Diagnostics Development, Loxo Oncology
Eli Lilly
Atul Butte
Chief Data Scientist
University of California Health
Hoi-Ying Elsie Yu
Laboratory Director, Point-of-Care Testing
Geisinger Health
Esther Babady
Section Head, Clinical Microbiology
Memorial Sloan Kettering Cancer Center
Jeffrey Venstrom
CMO
GRAIL
Razelle Kurzrock
CMO
Worldwide Innovative Network for Personalized Cancer Therapy
Jonathan Carlson
Managing Director
Microsoft Health Futures
Sonya Makhni
Medical Director
Mayo Clinic Platform
Ezra Cohen
CMO, Oncology
Tempus Labs
Howard Scher
Head, Biomarker Development
Memorial Sloan Kettering Cancer Center
Jean-Francois Martini
Diagnostics Lead, Oncology
Pfizer
Lourdes Barrera
Executive Director, Precision Medicine
Merck
Christopher Hartshorn
Chief, Digital & Mobile Technologies
NCATS
Jai Pandey
Head, Global Device Regulatory IVD/CDx
Sanofi
George Vacek
Global Head, Genomics Alliances
NVIDIA
Larissa May
Director, Emergency Medicine Innovation
UC Davis Health
Peter Bach
CMO
Delfi Diagnostics
Anne Beaubrun
VP, Global Health Economics & Outcomes
Cepheid
Yuan Luo
Chief AI Officer, Northwestern Univ.
Feinberg School of Medicine
John Mattison
Chief Medical Information Officer
Arsenal Capital Partners
Jennifer Quigley
Sr. Director, Precision Diagnostics
Novartis
Scott Penberthy
Managing Director, Applied AI
Google Cloud
Sudhir Srivastava
Chief, Cancer Biomarkers Research
NCI
Edward Abrahams
President
Personalized Medicine Coalition
Jonathan Beer
Sr. Director, Diagnostic Science
Bristol Myers Squibb
Jim Almas
VP, Clinical Effectiveness
LabCorp
Stacey DaCosta Byfield
VP, Genomic Health Economics and Outcomes
Optum Labs
Larry Kessler
Co-Chair
MCED Consortium
Noah Zimmerman
VP, Translational Science
Tempus
Mark Gardner
SVP, Molecular Genomics
Quest Diagnostics
Lesley Northrop
Chief Diagnostic Officer
Everly Health
Charles Chiu
Director, Clinical Microbiology Laboratory
UCSF
Christopher Conn
Director, Diagnostics Strategy
Amgen
TRI-CON 2023 盛况
